# Lidocaine, Paracetamol, and Dexmedetomidine for Rocuronium Injection Pain

> **NCT07169227** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Baskent University** · enrollment: 170 (estimated)

## Conditions studied

- Propofol Injection Pain
- Rocuronium Injection Pain

## Interventions

- **DRUG:** Lidocaine %2 ampoule
- **DRUG:** Dexmedetomidine
- **DRUG:** paracetamol

## Key facts

- **NCT ID:** NCT07169227
- **Lead sponsor:** Baskent University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2025-10
- **Final completion:** 2025-10
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2025-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07169227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07169227, "Lidocaine, Paracetamol, and Dexmedetomidine for Rocuronium Injection Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07169227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*